Showing results (2041-2050 of 2,089) with videos related to
Sort By:
Pageof 209
Korean Circulation Journal|November 25, 2017
Bioresorbable Vascular Scaffold Korean Expert Panel ReportJung Min Ahn, Duk Woo Park, Sung Jin Hong, et al.Clinical Therapeutics|December 11, 2017
Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled TrialChee Hae Kim, Kyung Ah Han, Jaemyung Yu, et al.Carcinogenesis|March 24, 2021
microRNA-320b suppresses HNF4G and IGF2BP2 expression to inhibit angiogenesis and tumor growth of lung cancerYu-Shui Ma, Bo-Wen Shi, Jun-Hong Guo, et al.Cell Research|May 22, 2019
Author Correction: 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancersWenshuai Li, Xu Zhang, Xingyu Lu, et al.Cell Research|September 20, 2017
5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancersWenshuai Li, Xu Zhang, Xingyu Lu, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|August 24, 2023
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trialEun Joo Cho, Moo Hyun Kim, Young-Hak Kim, et al.Lipids in Health and Disease|November 20, 2016
Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitusHyung Joon Joo, Sang-A Cho, Soon Jun Hong, et al.The Journal of Invasive Cardiology|July 21, 2022
Efficacy and Safety of 3 Versus 6 Months of Dual-Antiplatelet Therapy in Patients Implanted With a Coroflex ISAR Stents: A Prospective, Multicenter, Randomized Clinical TrialUram Jin, Kyoung-Woo Seo, Hyoung-Mo Yang, et al.Hypertension (Dallas, Tex. : 1979)|February 20, 2026
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCTJeong Cheon Ahn, Cheol Whan Lee, Jong Hwa Ahn, et al.Circulation|March 31, 2017
Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve)Jung-Min Ahn, Duk-Woo Park, Eun-Seok Shin, et al.Pageof 209